gefitinib has been researched along with gsk343 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (gsk343) | Trials (gsk343) | Recent Studies (post-2010) (gsk343) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 43 | 0 | 43 |
| Protein | Taxonomy | gefitinib (IC50) | gsk343 (IC50) |
|---|---|---|---|
| Polycomb protein EED | Homo sapiens (human) | 0.122 | |
| Histone-binding protein RBBP4 | Homo sapiens (human) | 0.122 | |
| Polycomb protein SUZ12 | Homo sapiens (human) | 0.122 | |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 1.0255 | |
| Histone-binding protein RBBP7 | Homo sapiens (human) | 0.004 | |
| Zinc finger protein AEBP2 | Homo sapiens (human) | 0.24 | |
| Histone-lysine N-methyltransferase EZH1 | Homo sapiens (human) | 0.24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, J; Gong, H; Li, W; Li, Y; Liu, C; Liu, H; Liu, M; Shi, R; Yuan, Y; Zhang, H; Zhang, Z | 1 |
1 other study(ies) available for gefitinib and gsk343
| Article | Year |
|---|---|
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Topics: Adenosine; Adult; Aged; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Humans; Indazoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Protein Kinase Inhibitors; Pyridones; RNA Interference; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction | 2020 |